
Formats: [HTML](/news/2006/07/13/merck-co-wins-a-trial-over-a-grandmother-s-claim-that-its-vioxx-painkiller-caused-her-to-have-a-heart-attack-reducing-pressure-on-the-c.html)  [JSON](/news/2006/07/13/merck-co-wins-a-trial-over-a-grandmother-s-claim-that-its-vioxx-painkiller-caused-her-to-have-a-heart-attack-reducing-pressure-on-the-c.json)  [XML](/news/2006/07/13/merck-co-wins-a-trial-over-a-grandmother-s-claim-that-its-vioxx-painkiller-caused-her-to-have-a-heart-attack-reducing-pressure-on-the-c.xml)  

### [2006-07-13](/news/2006/07/13/index.md)

##### Merck & Co.
#  Merck & Co. wins a trial over a grandmother's claim that its Vioxx painkiller caused her to have a heart attack, reducing pressure on the company to settle 12,000 other cases about the drug. 




### Sources:

1. [Bloomberg](https://www.bloomberg.com/apps/news?pid=20601103&sid=aTBzuWXmX._M)

### Related:

1. [ A United States federal judge overturns a jury's recent $50 million award against Merck on behalf of a Vioxx user, on the ground that the award was excessive. ](/news/2006/08/30/a-united-states-federal-judge-overturns-a-jury-s-recent-50-million-award-against-merck-on-behalf-of-a-vioxx-user-on-the-ground-that-the-a.md) _Context: Merck & Co., Vioxx_
2. [The United States Food and Drug Administration approves the Merck & Co. drug, Bridion, that reverses the effects of muscle relaxants used during surgery. ](/news/2015/12/15/the-united-states-food-and-drug-administration-approves-the-merck-co-drug-bridion-that-reverses-the-effects-of-muscle-relaxants-used-du.md) _Context: Merck & Co._
3. [Merck agrees to buy "superbug"-fighter Cubist Pharmaceuticals for $9.5 billion. ](/news/2014/12/8/merck-agrees-to-buy-superbug-fighter-cubist-pharmaceuticals-for-9-5-billion.md) _Context: Merck & Co._
4. [Merck & Co. agrees to buy Idenix Pharmaceuticals for US$3.85 billion. ](/news/2014/06/9/merck-co-agrees-to-buy-idenix-pharmaceuticals-for-us-3-85-billion.md) _Context: Merck & Co._
5. [Merck announces that a new drug, ragweed AIT, significantly reduced ragweed allergy symptoms in a Phase III clinical trial. ](/news/2012/03/5/merck-announces-that-a-new-drug-ragweed-ait-significantly-reduced-ragweed-allergy-symptoms-in-a-phase-iii-clinical-trial.md) _Context: Merck & Co._
